{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:06:00Z","timestamp":1785575160493,"version":"3.56.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019912","name":"Extracorporeal Life Support Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.healun.2020.01.1330","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T19:52:15Z","timestamp":1580241135000},"page":"639-647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Understanding risk factors and predictors for stroke subtypes in the ENDURANCE trials"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5132-0958","authenticated-orcid":false,"given":"Sung-Min","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall C.","family":"Starling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Teuteberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Hiivala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2020.01.1330_bib0001","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","article-title":"Seventh INTERMACS annual report: 15,000 patients and counting","volume":"34","author":"Kirklin","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2020.01.1330_bib0002","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.healun.2016.12.010","article-title":"Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices","volume":"36","author":"Frontera","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2020.01.1330_bib0003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12028-017-0386-7","article-title":"Stroke and intracranial hemorrhage in HeartMate II and HeartWare left ventricular assist devices: A systematic review","volume":"27","author":"Cho","year":"2017","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.healun.2020.01.1330_bib0004","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jacc.2013.08.1656","article-title":"Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients","volume":"63","author":"Boyle","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2020.01.1330_bib0005","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.athoracsur.2014.02.041","article-title":"Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients","volume":"97","author":"Whitson","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2020.01.1330_bib0006","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.healun.2013.08.021","article-title":"Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant","volume":"33","author":"Cowger","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2020.01.1330_bib0007","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa1602954","article-title":"Intrapericardial left ventricular assist device for advanced heart failure","volume":"376","author":"Rogers","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2020.01.1330_bib0008","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cardfail.2014.10.019","article-title":"Persistent blood stream infection in patients supported with a continuous-flow left ventricular assist device is associated with an increased risk of cerebrovascular accidents","volume":"21","author":"Trachtenberg","year":"2015","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2020.01.1330_bib0009","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/MAT.0000000000000901","article-title":"What causes LVAD-associated Ischemic Stroke? surgery, pump thrombosis, antithrombotics, and infections","volume":"65","author":"Cho","year":"2019","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2020.01.1330_bib0010","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12028-018-0662-1","article-title":"Stroke risk following infection in patients with continuous-flow left ventricular assist device","volume":"31","author":"Cho","year":"2019","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.healun.2020.01.1330_bib0011","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MAT.0000000000000887","article-title":"The impact of infection and elevated INR in LVAD-associated intracranial hemorrhage: A case-crossover study","volume":"65","author":"Cho","year":"2019","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2020.01.1330_bib0012","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jchf.2018.05.012","article-title":"HVAD: the ENDURANCE supplemental trial","volume":"6","author":"Milano","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2020.01.1330_bib0013","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.healun.2020.01.1330_bib0014","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacc.2010.05.016","article-title":"Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation","volume":"56","author":"Uriel","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2020.01.1330_bib0015","doi-asserted-by":"crossref","first-page":"E1321","DOI":"10.21037\/jtd.2016.10.81","article-title":"Bleeding in continuous flow left ventricular assist device recipients: an acquired vasculopathy?","volume":"8","author":"Patel","year":"2016","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.healun.2020.01.1330_bib0016","first-page":"2334","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Rosenstein","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2020.01.1330_bib0017","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1378\/chest.129.5.1155","article-title":"Effect of study setting on anticoagulation control: a systematic review and metaregression","volume":"129","author":"van Walraven","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.healun.2020.01.1330_bib0018","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.107.750000","article-title":"Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range","volume":"118","author":"Connolly","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2020.01.1330_bib0019","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1160\/TH11-05-0353","article-title":"Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients","volume":"106","author":"Gallagher","year":"2011","journal-title":"Thromb Haemost"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249820313474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249820313474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:38:37Z","timestamp":1760949517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249820313474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1053249820313474"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2020.01.1330","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding risk factors and predictors for stroke subtypes in the ENDURANCE trials","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2020.01.1330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}